Orange Book product · Generic (ANDA)
CARBOPLATIN
CARBOPLATIN
At a glance
Sep 19, 2008
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Sep 19, 2008
18 yr ago
Today
Pharmaceutical detail
Active ingredient
CARBOPLATIN
Strength
50MG/5ML (10MG/ML)
Dosage form
INJECTABLE
Route
INTRAVENOUS
TE code
AP
Application
ANDA 077926
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of CARBOPLATIN
- 2025KYXATABrand (NDA)
NDA 219921 · AVYXA HOLDINGS
- 2003PARAPLATINBrand (NDA)
NDA 020452 · CORDENPHARMA
- 1989PARAPLATINBrand (NDA)
NDA 019880 · CORDEN PHARMA
- 2026CARBOPLATINGeneric (ANDA)
ANDA 219999 · QILU PHARM HAINAN
- 2020CARBOPLATINGeneric (ANDA)
ANDA 206775 · ACCORD HLTHCARE
- 2017CARBOPLATINGeneric (ANDA)
ANDA 208487 · INGENUS PHARMS LLC
- 2017CARBOPLATINGeneric (ANDA)
ANDA 207324 · GLAND
- 2016CARBOPLATINGeneric (ANDA)
ANDA 205487 · EUGIA PHARMA
- 2012CARBOPLATINGeneric (ANDA)
ANDA 091510 · NATCO PHARMA USA
- 2012CARBOPLATINGeneric (ANDA)
ANDA 078732 · ACTAVIS TOTOWA
- 2011CARBOPLATINGeneric (ANDA)
ANDA 091478 · PHARMOBEDIENT
- 2011CARBOPLATINGeneric (ANDA)
ANDA 091063 · PHARMOBEDIENT
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
